XW-10508

N/A

Report date: 2025/01/14 15:50:36
NME

Base Information

Drug NameXW-10508
Drug Alias NameXW-10508
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonistsGlutamate [NMDA] receptor antagonists
TargetsGlutamate receptor ionotropic AMPAGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, MajorChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXw Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesXW Laboratories (Australia) Pty LtdXw Laboratories Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia